** Test Mode **

  0.00 (USD)

This Package provides access to the entire event

Registration Header
REGISTER TODAY!

Merck to Acquire Prometheus Biosciences Inc.

Start Date:4/17/2023

Start Time:8:00 AM EDT

Duration:60 minutes

Abstract:

$-[WCAbstract]-$

If you're already registered for the Merck to Acquire Prometheus Biosciences Inc. webcast, click below:

ALREADY REGISTERED?

Speakers

Robert M. Davis

Chairman and Chief Executive Officer

Dr. Dean Y. Li

Executive Vice President and President, Research Laboratories

Dr. Eliav Barr, MD

SVP, Head of Global Clinical Development & Chief Medical Officer

Chirfi Guindo

Chief Marketing Officer, Human Health

Caroline Litchfield

Executive Vice President and Chief Financial Officer

Dr. Aileen Pangan

VP, Late-Stage Immunology

Peter Dannenbaum

Senior Vice President, Investor Relations

Share on Facebook Share on Twitter Share on Linkedin Share through Email

Sponsors

Sponsor Image
Merck to Acquire Prometheus Biosciences Inc.
Registration Is Closed
Already Registered? Technical Requirements System Check